Systolic Blood Pressure Intervention Trial (SPRINT) displayed that intensive dropping of systolic BP to <120 mm Hg was advantageous, in comparison to standard treatment in which systolic BP is brought down to <140 mm Hg. The primary finish of the review has been undermined by the suggestion that the consequences of SPRINT were for the most part determined by the decrease of heart failure events. Given that, this researched study meant to survey whether the intensive treatment bunch was additionally connected with a diminished danger of cardiovascular events when heart failure occasions were omitted from the primary composite endpoint. The SPRINT information was assessed with a redefined composite endpoint including myocardial localized necrosis, intense coronary condition other than myocardial infarction, stroke, and cardiovascular death (barring cardiovascular breakdown occasions). The outcomes show that intensive treatment (<120 mm Hg) is related to a decreased danger for the redefined composite endpoint (hazard ratio, 0.79 [95% CI, 0.66–0.95]; P = 0.012), as matched with the standard treatment (<140 mm Hg), and with results like the first SPRINT discoveries (risk proportion, 0.75 [95% CI, 0.64–0.89]; P < 0.001). Generally speaking, the main results of SPRINT are not driven by a decrease in heart failure occasions. In addition to that, this post hoc analysis upholds the utilization of a more intensive treatment procedure for high-hazard hypertensive patients.